AAAAI & ACAAI GUIDELINES Bundle (free trial)

Primary Immunodeficiency

AAAAI & ACAAI GUIDELINES Apps brought to you free of charge courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/802140

Contents of this Issue

Navigation

Page 44 of 59

45 • 6.1 – A patient is suspected to have an autoinflammatory (episodic fever) syndrome. • 6.2 – It is first necessary to evaluate for other causes of recurrent or continual inflammation, such as other PIDDs, autoimmune disease, or malignancy. • 6.3 – If alternative (nonautoinflammatory) diagnoses are now suspected as a result of further clinical study, then these should be pursued and ruled out before additional investigation of autoinflammatory conditions is undertaken. • Note that nonspecific autoantibodies (eg, anti-nuclear antibody, rheumatoid factor, anti–double-stranded DNA, anti-phospholipid antibody, and anti- neutrophil cytoplasmic antibody) can be persistently or transiently present at mildly or moderately increased levels, especially in the noninflammasome defects. • If the clinical presentation has features strongly suggestive of an autoinflammatory component (eg, very early onset), such a diagnosis should still be entertained. • 6.4 – Early-onset severe pustular skin disease is seen in patients with DIRA and DITRA. • DIRA is also associated with bone involvement with osteopenia and lytic bone lesions. • Sequence analysis for IL1RN and IL36RN, as well as chromosomal analysis for deletions in the IL1 locus, should be investigated. • 6.5 – If an evanescent nonurticarial rash is present with cold exposure, genetic testing of CIAS1 should be done to test for FCAS, as well as NLRP13. If the rash is a cold- induced urticarial rash, the patient should be tested for mutation of PLCG2 (PLAID). • 6.6 – If fevers are associated with pyogenic arthritis and ulcerative skin lesions (ie, pyoderma gangrenosum), cystic acne, or both, mutational analysis of the PSTPIP1 gene should be evaluated for PAPA syndrome. • 6.7 – If granulomatous disease (rash, uveitis, or arthritis) is apparent, mutational analysis of NOD2 should be considered for Blau syndrome. • 6.8 – If febrile attacks are associated with abdominal or joint pains or rash, mutation analysis of pyrin, TNF receptor I, and MVK should be undertaken. • 6.9 – If bone lesions and dyserythropoietic anemia are associated with fevers, analysis of LPIN2 for Majeed syndrome should be considered. • 6.10 – If the presentation consists of purpura with 1 or more of lipodystrophy, contractures, or muscle atrophy, a defect in PSMB8 should be investigated. Figure 6. Diagnosis of Autoinflammatory Syndromes Notes

Articles in this issue

Archives of this issue

view archives of AAAAI & ACAAI GUIDELINES Bundle (free trial) - Primary Immunodeficiency